<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04983329</url>
  </required_header>
  <id_info>
    <org_study_id>202107031</org_study_id>
    <nct_id>NCT04983329</nct_id>
  </id_info>
  <brief_title>Systematic Quality Improvement With Realtime Event Support</brief_title>
  <acronym>SQUIRES</acronym>
  <official_title>Systematic Quality Improvement With Realtime Event Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to improve perioperative quality metric performance in patients&#xD;
      receiving anesthesia care provided by Washington University Department of Anesthesiology. In&#xD;
      this protocol, we describe (1) the use of telemedicine-augmented quality improvement&#xD;
      interventions to enhance on-time dosage of surgical prophylactic antibiotics, while (2)&#xD;
      carrying out large scale monitoring of surgical site infection incidence in the target&#xD;
      population. If this quality improvement framework is found to be feasible and successful, we&#xD;
      plan subsequently to study its application to additional perioperative quality metrics,&#xD;
      including many pertinent to surgical site infection incidence such as perioperative glucose&#xD;
      monitoring and management, and intraoperative temperature management.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in administration of surgical antibiotic prophylaxis- intervention period</measure>
    <time_frame>3 months</time_frame>
    <description>1a. Increase the rate of on-time surgical antibiotic prophylaxis administration prior to incision during the intervention period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in administration of surgical antibiotic prophylaxis-after quality improvement intervention</measure>
    <time_frame>2 months</time_frame>
    <description>1b. Increase the rate of on-time surgical antibiotic prophylaxis administration prior to incision six weeks after the quality improvement intervention is completed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in administration of surgical antibiotic prophylaxis</measure>
    <time_frame>8 months</time_frame>
    <description>1c. Increase the rate of on-time re-dosing of antibiotic prophylaxis throughout the duration of the trial.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical site infection rate</measure>
    <time_frame>8 months</time_frame>
    <description>Decrease the proportion of patients which develop surgical site infections throughout the duration of the trial.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40000</enrollment>
  <condition>Telemedicine</condition>
  <arm_group>
    <arm_group_label>Improvement in administration of surgical antibiotic prophylaxis.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The eight-month module will include a baseline phase, educational interventions, real-time guidance from a remote telemedicine center, regular feedback regarding adherence to protocols related to that module, and continued silent monitoring.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine intervention</intervention_name>
    <description>Following education, the telemedicine center will subsequently monitor operating rooms included in this trial for protocol adherence for three-months. The telemedicine center is staffed by attending anesthesiologists, resident anesthesiologists, certified registered nurse anesthetists (CRNAs) and student registered nurse anesthetists (SRNAs) and is currently providing evidence-based support to clinicians in a subset of operating rooms and post-anesthesia care unit (PACU) beds at Barnes-Jewish Hospital.</description>
    <arm_group_label>Improvement in administration of surgical antibiotic prophylaxis.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients having procedures at Barnes-Jewish Hospital in suites not part of the&#xD;
             TECTONICS trial will be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients enrolled in the ongoing TECTONICS intraoperative Anesthesiology Control Tower&#xD;
             telemedicine trial at Barnes-Jewish Hospital will be excluded from this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Troy Wildes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington Univeristy School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thaddeus Budelier</last_name>
    <phone>314-747-0421</phone>
    <email>thaddeus.budelier@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sherry L McKinnon</last_name>
    <phone>314-286-1768</phone>
    <email>smckinnon@wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Washington University School of Medicine/Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thaddeus Budelier</last_name>
      <phone>314-747-0421</phone>
      <email>thaddeus.budelier@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Arbi Ben Abdallah, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Avidan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ryan Guffey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernadette Henrichs</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivan Kangrga, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Teresa Murray-Torres, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Reidy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Torres</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachel Wolfe</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 16, 2021</study_first_submitted>
  <study_first_submitted_qc>July 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington University School of Medicine</investigator_affiliation>
    <investigator_full_name>Troy Wildes, MD</investigator_full_name>
    <investigator_title>Assoc Prof of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Telemedicine</keyword>
  <keyword>Quality-Improvement</keyword>
  <keyword>surgical antibiotics</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

